Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DMAADMAA
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DRUGS MADE IN AMER ACQUTN CO

GOLDMAN SACHS GROUP INC previously held 0 shares of DMAA (DRUGS MADE IN AMER ACQUTN CO), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.2M

Total Shares Change

-119,686

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$10.65
0
2026-Q1
Unchanged
119,686
0.0%
$1.3M0.0%$10.46
0
2025-Q4
Unchanged
119,686
0.0%
$1.2M0.0%$10.37
0
2025-Q3
Unchanged
119,686
0.0%
$1.2M0.0%$10.27
0
2025-Q2
Unchanged
119,686
0.0%
$1.2M0.0%$10.19
0
2025-Q1
New
119,686
-
$1.2M0.0%$10.04
35

Other major holders of DMAA: Hudson Bay Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used